M4MM

Colorado Considers Psilocybin Prescription Legislation

LOS ANGELES- Colorado lawmakers have introduced House Bill 25-1063, a bipartisan proposal that would permit the prescription of crystalline polymorph psilocybin—a synthetic form of the psychedelic compound—contingent upon approval by the U.S. Food and Drug ...

High Tide Acquires Majority Stake in German Cannabis Firm

LOS ANGELES- High Tide Inc., a Canadian cannabis enterprise, has acquired a 51% stake in Frankfurt-based pharmaceutical company Purecan for approximately €4.8 million. This strategic move marks High Tide's entry into Germany's medical cannabis market. ...

MindMed to Present at Key September Investor Conferences

LOS ANGELES- Mind Medicine (MindMed) Inc., a clinical-stage biopharmaceutical company focused on developing novel treatments for brain health disorders, announced its participation in three significant investor conferences in September 2024. MindMed’s management team will engage ...

Colorado Considers Psilocybin Prescription Legislation

LOS ANGELES- Colorado lawmakers have introduced House Bill 25-1063, a bipartisan proposal that would permit the prescription of crystalline polymorph psilocybin—a synthetic form of the psychedelic compound—contingent upon approval by the U.S. Food and Drug ...

High Tide Acquires Majority Stake in German Cannabis Firm

LOS ANGELES- High Tide Inc., a Canadian cannabis enterprise, has acquired a 51% stake in Frankfurt-based pharmaceutical company Purecan for approximately €4.8 million. This strategic move marks High Tide's entry into Germany's medical cannabis market. ...

Canntab Signs Affiliate Agreement With Onpharm-United

TORONTO - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F), an innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that the Company has entered into ...

Subscribe To Our Newsletter